Loss of RUNX3 expression promotes cancer‐associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non‐small cell lung cancer

Non‐small cell lung cancer (NSCLC) frequently metastasizes to bone, which is associated with significant morbidity and a dismal prognosis. RUNX3 functions as a tumour suppressor in lung cancer and loss of expression occurs more frequently in invasive lung adenocarcinoma than in pre‐invasive lesions....

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyun‐Jeong, Park, Junhee, Lee, Sun Kyoung, Kim, Ki Rim, Park, Kwang‐Kyun, Chung, Won‐Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832375/
https://www.ncbi.nlm.nih.gov/pubmed/26239696
http://dx.doi.org/10.1002/path.4597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832375/
https://www.ncbi.nlm.nih.gov/pubmed/26239696
http://dx.doi.org/10.1002/path.4597

Ejemplares similares